Evopoint Biosciences Co., Ltd. (SHA:688837)
China flag China · Delayed Price · Currency is CNY
33.98
-1.23 (-3.49%)
Nov 17, 2026, 3:00 PM CST

Evopoint Biosciences Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.631.281.450.710.79
Debt / EBITDA Ratio
-3.59---
Debt / FCF Ratio
-7.77---
Net Debt / Equity Ratio
-0.600.110.38-0.20-0.15
Net Debt / EBITDA Ratio
2.890.33-0.310.270.13
Net Debt / FCF Ratio
2.380.69-0.350.260.12
Asset Turnover
-0.66---
Quick Ratio
4.212.661.242.672.52
Current Ratio
4.342.951.372.782.61
Return on Equity (ROE)
-38.13%-82.26%-82.22%-
Return on Assets (ROA)
-9.28%-25.96%-27.41%-
Return on Invested Capital (ROIC)
-55.86%22.51%-96.44%-105.74%-133.77%
Return on Capital Employed (ROCE)
-15.60%14.70%-59.40%-48.20%-70.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Payout Ratio
-11.89%---
Buyback Yield / Dilution
-0.93%-0.18%-7.65%-4.82%-